Videos

Dr. Frost talks about the results of the Halozyme study and the positive results, including a drop in A1c from the 8 range in type 2 diabetes patients to around 6.8. He also lets us know how the reduced use of better-designed insulins could even result in some weight loss, …

  Steven J. Russell MD, PhD, Department of Cellular and Molecular Physiology, Joslin Diabetes Center, Harvard Medical School, explains that, in his studies with a closed-loop system, using CGM in real-time is proving to be a highly effective motivational tool….

Dr. Carol Wysham discusses the most difficult challenges in managing patients today suggesting that measuring adherence, setting reasonable limits, and coordination of the monitoring of medication adherence are among those challenges….  

Silva A. Arslanian, MD, talks about the particular challenges of type 2 diabetes in adolescence and the role parents should but often do not play in helping to manage their children’s diabetes….

Dr. Arslanian confirms that she is seeing a higher incidence of type 2 diabetes in children in lower socio-economic classes, where there is also a higher obesity rate. More videos with Dr. Arslanian: Silva A. Arslanian, MD, Introduction T2DM in Children – Earlier co-morbidities? What drugs can be prescribed to …

Silva A. Arslanian, MD, explains the rigorous process for gaining approval for new diabetes drugs for children, and points out that the type 2 rate is not yet at epidemic proportions in children (as it is in adults)….

With all of the discussion in the medical community and beyond regarding new drug approvals for diabetes, it is easy to forget that many of these drugs are not approved for children and adolescents. Silva A. Arslanian, MD, Professor of Pediatrics, University of Pittsburgh School of Medicine, explains why this is and describes …

Dr. Arslanian talks about the earlier incidence rate of ESRD of people who have type 2 in childhood as well as her own team’s studies on cardiovascular markers, and the premature “aging” of the CV system seen in these individuals. She also discusses the challenges of children growing up in …

Dr. Arslanian introduces herself and describes her recent research and the “sobering reality” of researching type 2 in children and adolescents.  More videos with Dr. Arslanian: T2DM in Children – Earlier co-morbidities? What drugs can be prescribed to children with diabetes? How does the drug approval process differ for children? …